Concepedia

User-administered Glucagon

User-Administered Glucagon is a glucagon-based therapeutic formulation designed for self-application by individuals with diabetes to rapidly counteract severe hypoglycemia, distinguished from clinician-administered glucagon by its pre-filled, simplified delivery system enabling use in non-medical settings.

8

Publications

225

Citations

60

Authors

34

Institutions

Publications per year

2017–2026

6

Variants

Self-administered Glucagon

Parents

Publications

8

Faster Use and Fewer Failures with Needle-Free Nasal Glucagon Versus Injectable Glucagon in Severe Hypoglycemia Rescue: A Simulation Study

Jean‐François Yale, Hélène Dulude, Marc Egeth et al. · Diabetes Technology & Therapeutics · 2017 · 88 citations · Full text

, , +16

Glucagon use by U.S. adults with type 1 and type 2 diabetes

Peter A. Kahn, Rozalina G. McCoy, Robert A. Gabbay et al. · Journal of Diabetes and its Complications · 2021 · 27 citations · Full text

, , +15

Factors affecting the success of glucagon delivered during an automated closed-loop system in type 1 diabetes

Parkash A. Bakhtiani, Joseph El Youssef, Anna K. Duell et al. · Journal of Diabetes and its Complications · 2014 · 25 citations · Full text

, , +14

Glucagon Prescriptions for Diabetes Patients after Emergency Department Visits for Hypoglycemia

A. Mark Fendrick, Xuanyao He, Dongju Liu et al. · Endocrine Practice · 2018 · 21 citations

, , +15

Human factors studies of a prefilled syringe with stable liquid glucagon in a simulated severe hypoglycemia rescue situation

Brett Newswanger, Steven J. Prestrelski, Anthony D. Andre · Expert Opinion on Drug Delivery · 2019 · 18 citations · Full text

, , +16

1–5 of 8

Authors

60

  1. BM
    Beth Mitchell

    Eli Lilly (United States), United States

    2 publications · 36 citations

    2

    h-index

  2. SZ
    Shuyu Zhang

    Soochow University, China

    2 publications · 103 citations

    2

    h-index

  3. KY
    Kenichi Yamada

    Niigata University, Japan

    1 publications · 16 citations

    1

    h-index

  4. KY
    Katsuyuki Yanagisawa

    Hokkaido University, Japan

    1 publications · 16 citations

    1

    h-index

  5. DB
    Deborah Branigan

    Oregon Health & Science University, United States

    1 publications · 25 citations

    1

    h-index

1–5 of 60

Institutions

34

  1. Eli Lilly (United States)

    Indianapolis, United States

    4 h-index

    8 publications

    284 citations

  2. The Jikei University Hospital

    Tokyo, Japan

    1 h-index

    1 publications

    15 citations

  3. Optum (United States)

    Eden Prairie, United States

    1 h-index

    1 publications

    27 citations

  4. Wichita Clinic

    Wichita, United States

    1 h-index

    2 publications

    32 citations

  5. Heart Life Hospital

    Okinawa, Japan

    1 h-index

    1 publications

    16 citations

  6. Xeris Pharmaceuticals (United States)

    Austin, United States

    1 h-index

    2 publications

    36 citations

  7. Miwa Internal Medicine Clinic

    Chigasaki, Japan

    1 h-index

    1 publications

    16 citations

  8. Sendai Tateyama Tanaka School

    Sendai, Japan

    1 h-index

    1 publications

    16 citations

1–8 of 34

Venues

  1. Journal of Diabetes and its Complications

    2 publications · 52 citations

    2

    h-index

  2. Diabetes Technology & Therapeutics

    2 publications · 104 citations

    2

    h-index

  3. Expert Opinion on Drug Delivery

    1 publications · 18 citations

    1

    h-index

  4. Endocrine Practice

    1 publications · 21 citations

    1

    h-index

  5. Diabetes Therapy

    1 publications · 15 citations

    1

    h-index

1–5